The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 150 mg/mL XOLAIR syringes and does not have a set-aside designation.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a range of pharmaceutical products to support the medical supply needs of military healthcare facilities. This latest award further solidifies DMS Pharmaceutical Group's position as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to the Department of Defense.
Generated 3/18/25, 9:52 AM